The FDA’s unprecedented criminal case against an alternative funding program hinged on the cooperation of a peer CEO, according to a court record.
Trending
- How NBA rookies are doing through first month of season
- Czech Republic bars Russia’s team from under-18 women’s ice hockey worlds
- Miami Heat all in on ‘Grand Theft Auto VI’ collaboration
- Why you should bet the over on SNF, lock in Chiefs’ Mahomes for another MVP
- Canadian women’s, men’s flag football teams to hold camps in California
- Why Raptors’ defensive versatility will shine through with healthy lineup
- Cowboys pull play-calling duties from defensive co-ordinator
- Zverev officially notified of lawsuit by ex-partner in abuse case
